hrp0097p2-270 | Late Breaking | ESPE2023

The effect of dulaglutide (GLP-1agonist) and metformin combination on weight loss in obese patients with and without type 2 diabetes. Gold combination?

Zohrabyan Naira , Hakobyan Sonya

Background: GLP-1 agonists have a special place in the treatment of type 2 diabetes mellitus (T2DM). Dulaglutide is GLP-1agonist with important advantages, it doesn’t cause hypoglycemia, reduces weight and decreases HbA1c with sufficient level. GLP-1 agonists are also involved in the treatment of obesity.Objectives: The purpose of this study was to present the efficacy of Dulaglutide (GLP-1) in obesity with and wit...

hrp0097p2-146 | Pituitary, Neuroendocrinology and Puberty | ESPE2023

Some descriptive characteristics of hypopituitarism in children and adolescents in Armenia

Navasardyan Lusine , Zohrabyan Naira , Hakobyan Sona , Manvelyan Diana , Markosyan Renata , Bayburdyan Gayane , Arakelyan Lusine , Kalantaryan Lusine , Aghajanova Elena

Background: Hypopituitarism is a rare condition characterized by the insufficiency of 2 and more hormones produced by anterior pituitary gland. The major causes of hypopituitarism are brain tumors located near or in the pituitary gland and/or hypothalamus, cranial radiation, chemo- or surgical therapy, cranial traumas, neuroinfections, autoimmune hypophysitis (immune-mediated inflammation of pituitary gland) etc. Brain tumors are the second most frequent type ...